ArticleJournal of clinical medicine2021

Prognostic Value of Resistance Proteins in Plasma Cells from Multiple Myeloma Patients Treated with Bortezomib-Based Regimens.

Paweł Robak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.